We are currently upgrading our print fulfillment systems. Print book orders placed between Sept 22 and Oct 9 will be delayed. Delivery of these orders will start on Oct 10, with purchases being fulfilled in the order received. Buy the Print and get eBook immediately for FREE. Use Code BOGO. Or save up to 40% on all orders with code: DELTA. Exclusions apply. Click here for terms and conditions.
»
Target Validation in Drug Discovery
 
 

Target Validation in Drug Discovery, 1st Edition

 
Target Validation in Drug Discovery, 1st Edition,Brian Metcalf,Susan Dillon,ISBN9780123693938
 
 
 

Metcalf   &   Dillon   

Academic Press

9780123693938

9780080465975

296

260 X 184

Print Book + eBook

USD 135.00
USD 225.00

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 115.00

eBook
eBook Overview

VST format:

DRM Free included formats: PDF

USD 110.00
Add to Cart
 
 

Description

This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as "second generation" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book.

Readership

Professionals in biotechnology and pharmaceutical drug discovery and clinical development. Can also include students and academics in the related areas of study.

Brian Metcalf

Affiliations and Expertise

Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.

Susan Dillon

Affiliations and Expertise

Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.

Target Validation in Drug Discovery, 1st Edition

Section Contents
I. Pharmaceutical Biotechnology for Target Validation
II. Target Validation for Biopharmaceutical Drug Discovery
III. Validating Targets of Small Molecule Approaches
 
 
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ